Ismp Medication Error Benchmarking
Contents |
is the definition of a medication error? What are the “ten key elements” of the medication-use system? Won’t medication errors be prevented if nurses just follow the “Five Rights?” What are
Rate Of Medication Errors In Hospitals
"high-alert" medications? What abbreviations are dangerous? Are these evidence based? What drug benchmark data for medication errors names are frequently confused? How should tall man lettering be applied to differentiate look-alike/sound-alike drug names? What is confirmation bias?
Medication Error Rate Calculation
How do I do an independent double check? How can I measure culture? Should a healthcare practitioner be disciplined for being involved in an error? How can I assess risk? What medication safety ppt is the difference between high-leverage and low-leverage safety strategies? What is an FMEA, and how can I use it? How do I join ISMP? What ISMP resources are available for consumers? Why are standard concentrations safer than using the Rule of 6 for pediatric drips? What tools does ISMP have to satisfy regulatory or insurance network inclusion requirements for community pharmacies to demonstrate participation medication safety definition and knowledge in medication safe practices? Is there a way to get involved with ISMP as a student? Does ISMP have a nationally registered student-organization? 1. What is the national medication error rate? What standards are available for benchmarking? A national or other regional medication error rate does not exist. It is not possible to establish a national medication error rate or set a benchmark for medication error rates. Each hospital or organization is different. The rates that are tracked are a measure of the number of reports at a given institution not the actual number of events or the quality of the care given. Most systems for measuring medication errors rely on voluntary reporting of errors and near-miss events. Studies have shown that even in good systems, voluntary reporting only captures the "tip of the iceberg." For this reason, counting reported errors yields limited information about how safe a medication-use process actually is. It is very possible that an institution with a good reporting system, and thus what appears to be a high error "rate," may have a safer system. For more detailed information see Medication Errors, a boo
Know Governance Job Openings Login to PA-PSRS About PA-PSRS Data Interface Facility Reporting Information Login to PassKey About PassKey Advisory Library Patient and Consumer Tips Press Releases
Medication Use Process
Healthcare-Associated Infections Brochures Related Organization Links The Authority in the News Driving best practices for safe medication administration Change Patient Safety Tools Calendar Public Meetings ADDRESS: Patient Safety Authority 333 Market Street Lobby Level Harrisburg,
Medication Error Definition
PA 17120 Phone: 717-346-0469 Fax: 717-346-1090 SearchAdvanced Search Understanding the Benchmarking Process PA PSRS Patient Saf Advis 2004 Dec;1(4):19. _______________This article is excerpted from the book Medication http://www.ismp.org/faq.asp Errors by Michael Cohen, RPh, MS, ScD. Dr. Cohen is President of the Institute for Safe Medication Practices (ISMP) and serves as an expert advisor to PA-PSRS in the area of medication safety._______________Benchmarking is an ongoing process that determines how other organizations have achieved optimal performance. Through the process of benchmarking, ways are suggested for adapting the http://patientsafetyauthority.org/ADVISORIES/AdvisoryLibrary/2004/dec1(4)/Pages/19.aspx best practices that result in exception performance. Although measurement is one of its components, effective benchmarking is a dual process that requires two products: performance measurement and enablers.Benchmarks are measures of comparative performance that answer the question: What is your level of performance? By itself, this information has little use in improving performance. To be effective, benchmarking must also provide a systematic method of understanding the underlying process that determines an organization’s performance. To that end, enablers must be identified. Enablers are the specific practices that lead to exemplary performance; they answer the question: How do you do it? Overlooking either one of these components in the benchmarking process renders it useless, even dangerous.Although medication error rates, for example, may seem ideal for benchmarking, we must question the wisdom of applying the benchmarking concept to the medication use process when the focus is on error rates. Certainly, the confusion surrounding the term “benchmarking” perpetuates the myth that one can gauge the quality and safety of the medication use process simply by
Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products Drugs Home Drugs Drug http://www.fda.gov/drugs/drugsafety/medicationerrors/ Safety and Availability Medication Errors Medication Errors Related to Drugs Share Tweet Linkedin Pin it More sharing options Linkedin Pin it Email Print Within the Center for Drug Evaluation and Research (CDER), the Division of Medication Error Prevention and Analysis (DMEPA) reviews medication error reports on marketed human drugs including prescription drugs, generic drugs, and over-the-counter drugs. DMEPA uses the National Coordinating Council medication error for Medication Error Reporting and Prevention (NCCMERP) definition of a medication error. Specifically, a medication error is "any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems, including prescribing; ismp medication error order communication; product labeling, packaging, and nomenclature; compounding; dispensing; distribution; administration; education; monitoring; and use."DMEPA includes a medication error prevention program staffed with healthcare professionals. Among their many duties, program staff review medication error reports sent to MedWatch, evaluate causality, and analyze the data to provide solutions to reduce the risk of medication errors to industry and others at FDA.Additionally, DMEPA prospectively reviews proprietary names, labeling, packaging, and product design prior to drug approval to help prevent medication errors.Although DMEPA encourages manufacturers to perform their due diligence when naming their drug products and we strive to avoid approving confusing proprietary names for drug products, there are cases of adverse events where a name of a marketed product is identified as a source of confusion and error. Therefore, we continue to encourage healthcare providers, patients and consumers to report all medication errors to MedWatch so that we can be made aware of potential problems related to drug names and the Agency can provide effective interventions that will minimize further errors. In some situations, changing a proprietary name while the product is marketed may be necessary to address safety i